This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Wolverine Stack (BPC-157 + TB-500)
Two-peptide tissue-repair stack named for the Marvel character's regenerative ability.
Aliases (6)
Overview
What is Wolverine Stack (BPC-157 + TB-500)?
The Wolverine Stack is a popular peptide combination of BPC-157 (Body Protection Compound 157, a 15-amino-acid stomach-derived peptide) and TB-500 (a synthetic analog of thymosin beta-4). Used in performance and recovery contexts for accelerated healing of soft tissue, tendon, ligament, and gut injuries.
Key Benefits
Accelerates healing of musculoskeletal injuries (tendons, ligaments, muscle tears), supports gut repair and inflammatory bowel conditions, may aid wound healing and post-surgical recovery, and provides anti-inflammatory effects with reportedly low side-effect profile.
Mechanism of Action
BPC-157 promotes angiogenesis (new blood vessel formation), upregulates growth hormone receptor expression, modulates nitric oxide and dopamine systems, and aids gut mucosal healing. TB-500 (thymosin beta-4 fragment) enables actin sequestration and cell migration, accelerating tissue repair and stem cell migration to injury sites. Together, they cover both vascular and cellular repair phases of healing.
Stack Components
Local infrastructure builder — drives VEGFR2-Akt-eNOS angiogenesis at injury sites, mobilizes Schwann cells for peripheral nerve repair, upregulates growth hormone receptor expression, and tamps down TNF-α / IL-1β / IL-6 locally.
Systemic cell mobilizer — sequesters G-actin to drive endothelial-progenitor, keratinocyte, fibroblast, and stem-cell migration toward injury sites; reinforces BPC-157's angiogenic signal via secondary VEGF upregulation.
▸ Reconstitution Lyophilized peptide
Reconstitute lyophilized peptide with bacteriostatic water (BAC) using sterile technique. Calculator below converts vial mg + diluent mL into syringe units.
- 1 Wipe BAC water vial + peptide vial stoppers with isopropyl alcohol.
- 2 Draw the planned diluent volume into a 1 mL syringe.
- 3 Inject diluent slowly down the inside wall of the peptide vial — do NOT spray onto powder.
- 4 Swirl gently (do not shake) until fully dissolved. Solution should be clear.
- 5 Label vial with date reconstituted; refrigerate 2-8 °C.
- 6 Use within 30 days for most peptides (BPC-157 / TB-500 ~ 60 days at 4 °C).
Research Indications
Tendon & Ligament Healing
Both peptides show evidence for accelerated tendon and ligament repair. BPC-157 improved Achilles tendon healing in animal models; combination may enhance effects.
Muscle Injury Recovery
BPC-157 demonstrated enhanced muscle regeneration. TB-500 promotes cell migration essential for muscle repair. Commonly combined for athletic recovery.
Joint Pain & Cartilage
Lee & Padgett study showed 87.5% of knee pain patients improved with BPC-157/TB4. May support cartilage repair through enhanced chondrocyte activity.
Accelerated Wound Closure
TB-500 Phase 2 trials showed ~1 month faster healing in ulcer patients. BPC-157 promotes angiogenesis critical for wound healing.
Reduced Scarring
Thymosin β4 decreases myofibroblasts, reducing scar formation and fibrosis. Combined approach may minimize scarring.
Surgical Recovery
Theoretical application for post-surgical healing based on individual peptide wound healing data. No direct surgical studies on combination.
Peptide Interactions
BPC-157 upregulates GH receptors, potentially enhancing tissue repair effects. Combined use may accelerate recovery.
GH secretagogues complement the Wolverine Stack by increasing endogenous growth hormone, which supports tissue repair processes.
MGF activates satellite cells while BPC-157/TB-500 promote tissue repair through different pathways. May enhance muscle recovery.
Copper peptide promotes collagen synthesis and wound healing through different mechanisms. No negative interactions expected.
BPC-157 has shown protective effects against NSAID-induced GI damage in studies, but long-term combination effects unknown.
Steroids may counteract some healing effects. BPC-157 has shown ability to reverse some corticosteroid-induced damage in animal models.
Both peptides promote angiogenesis. Monitor for any bleeding issues when combined with blood thinners.
Angiogenesis promotion could theoretically support tumor growth. Contraindicated with any cancer history or treatment.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
Side Effects & Safety 6
Side Effects
- 1Injection site reactions (5%) — mild redness, swelling, transient pain
- 2Most users (68%) report no side effects
- 3Fatigue (5%)
- 4Headache (5%)
- 5Insomnia (2%)
- 6Dizziness (2%)
When to Stop
- Theoretical cancer promotion — both peptides drive angiogenesis; TB-4 is overexpressed in pancreatic, NSCLC, RCC, colorectal cancers (causation unresolved). Contraindicated with any active cancer or recent cancer history. Real concern flag for users with strong family cancer history.
- Bleeding risk on anticoagulants — angiogenesis + anticoagulation = monitor
- Counterfeit/contamination from gray-market sourcing — endotoxin contamination, wrong stoichiometry (especially for GHK-Cu adjunct), no-active-peptide vials
- First 2 weeks of cycle: injection-site reactions, sourcing quality assessment
- Weeks 4-6: mid-cycle assessment for objective improvement (Tinel's, flexion test, pain rating)
- 4 weeks post-cycle: durability assessment
References
BPC-157 + TB4 Knee Pain Study (Lee & Padgett, 2021)
only published human study combining the two; n=16, knee pain, 87.5% improvement
View StudyBPC-157 Systematic Review (Vasireddi et al., 2025)
36 articles, orthopedic sports medicine focus, HSS Journal
View StudyThymosin β4 Clinical Wound Healing (Treadwell et al., 2012)
Phase 2 stasis/pressure ulcers, accelerated healing
View StudyThymosin β4 Regenerative Properties Review (Goldstein et al., 2012)
multi-functional regenerative peptide review
View StudyBPC-157 Achilles Tendon Healing (2003)
00110-4) — rat Achilles transection, improved biomechanics
View StudyThymosin β4 Wound Healing Acceleration (1999)
rat full-thickness wounds, 42-61% faster re-epithelialization
View StudyHow was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.